Most read article(s)

You have access
G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
Krishna Sriram and Paul A. Insel

Molecular Pharmacology April 2018, 93 (4) 251-258; DOI: https://doi.org/10.1124/mol.117.111062
You have access
The Histamine H₃ Receptor: Structure, Pharmacology, and Function
Gustavo Nieto-Alamilla, Ricardo Márquez-Gómez, Ana-Maricela García-Gálvez, Guadalupe-Elide Morales-Figueroa and José-Antonio Arias-Montaño

Molecular Pharmacology November 2016, 90 (5) 649-673; DOI: https://doi.org/10.1124/mol.116.104752
You have access
Pharmacological characterization of the imipridone anti-cancer drug ONC201 reveals a negative allosteric mechanism of action at the D₂ dopamine receptor
R. Benjamin Free, Caroline A Cuoco, Bing Xie, Yoon Namkung, Varun V. Prabhu, Blair K.A. Willette, Marilyn M. Day, Marta Sanchez-Soto, J. Robert Lane, Stephane A. Laporte, Lei Shi, Joshua E. Allen and David R. Sibley

Molecular Pharmacology August 5, 2021, MOLPHARM-AR-2021-000336; DOI: https://doi.org/10.1124/molpharm.121.000336
Open Access
Wnt Signaling and Drug Resistance in Cancer
Zheng Zhong and David M. Virshup

Molecular Pharmacology February 2020, 97 (2) 72-89; DOI: https://doi.org/10.1124/mol.119.117978
You have access
Characterization of 6-Mercaptopurine Transport by the SLC43A3-Encoded Nucleobase Transporter
Nicholas M. Ruel, Khanh H. Nguyen, Gonzalo Vilas and James R. Hammond

Molecular Pharmacology June 2019, 95 (6) 584-596; DOI: https://doi.org/10.1124/mol.118.114389
You have access
Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators
Manoj Kumar, Nicholas Reed, Ruiting Liu, Elias Aizenman, Peter Wipf and Thanos Tzounopoulos

Molecular Pharmacology June 2016, 89 (6) 667-677; DOI: https://doi.org/10.1124/mol.115.103200
You have access
Membrane-facilitated receptor access and binding mechanisms of long-acting β2-adrenergic receptor (β2-AR) agonists
Christopher T. Szlenk, Jeevan B. GC and Senthil Natesan

Molecular Pharmacology August 1, 2021, MOLPHARM-AR-2021-000285; DOI: https://doi.org/10.1124/molpharm.121.000285
You have access
Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring
Nadine Wenningmann, Merle Knapp, Anusha Ande, Tanaya R. Vaidya and Sihem Ait-Oudhia

Molecular Pharmacology August 2019, 96 (2) 219-232; DOI: https://doi.org/10.1124/mol.119.115725
You have access
Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na⁺ Channels
Vaibhavkumar S. Gawali, Peter Lukacs, Rene Cervenka, Xaver Koenig, Lena Rubi, Karlheinz Hilber, Walter Sandtner and Hannes Todt

Molecular Pharmacology November 2015, 88 (5) 866-879; DOI: https://doi.org/10.1124/mol.115.099580
You have access
Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons
Alex Straiker, Michaela Dvorakova, Anaelle Zimmowitch and Ken Mackie

Molecular Pharmacology July 2018, 94 (1) 743-748; DOI: https://doi.org/10.1124/mol.118.111864

Main menu

User menu

Search

Most read article(s)

Pages

Navigate

More Information

ASPET's Other Journals